Principal
  1. Inicio
  2. CAIPaDi

Publicaciones

  1. Hernández-Jiménez S, Garcia-Ulloa AC, Mehta R, Aguilar-Salinas CA, Kershenobich D. Innovative Models for Empowering Patients with Type 2 Diabetes: The CAIPaDi program. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2014, 8 (3)
  2. Villegas-Narváez A, Urbina-Arronte Luz, García-Ulloa AC, Hernández-Jiménez S, por el Grupo de Trabajo CAIPaDi. Evaluación de la actividad física para alcanzar un estilo de vida activo en los profesionales de la salud: estudio piloto. Rev ALAD. 2018; 8:145-51
  3. López Reyes AS, Patiño-Rivera E, García-Ulloa AC, Hernández-Jiménez S, for the Group of Study CAIPaDi. Periodontal status at two years of follow-up in patients with Newly Diagnosis of type 2 Diabetes Mellitus. International Journal of Clinical Endocrinology and Metabolism 2019; 1-5. DOI: http://dx.doi.org/10.17352/ijcem
  4. Hernández-Jiménez S, García-Ulloa AC, Bello-Chavolla OY, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D, for the Group of Study CAIPaDi. Long-term effectiveness of a type 2 diabetes comprehensive care program. The CAIPaDi model. Diabetes Res Clin Pract. 2019; 151:128–137. doi: 10.1016/j.diabres.2019.04.009
  5. García-Ulloa AC, Landa-Anell V, Melgarejo-Hernández M, Villegas-Narváez A, Urbina-Arronte LE, Hernández-Jiménez S, for the CAIPaDi Study Group. Assessment of a multidisciplinary intervention in patients with BMI ≥35Kg/m2 and recently diagnosed type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism Vol 104, Issue 7, July 2019: 2994-3002. DOI: 10.1210/jc.2018-01148
  6. Landa-Anell MV, Melgarejo-Hernández MA, García-Ulloa AC, Del Razo-Olvera FM, Velázquez-Jurado HR, Hernández-Jiménez S, for the Group of Study CAIPaDi. Barriers to adherence to a nutritional plan and strategies to overcome them in patients with type 2 diabetes mellitus; results after two years of follow-up [published online ahead of print, 2019 Aug 3]. Endocrinol Diabetes Nutr. 2019; S2530-0164(19)30150-8. doi: 10.1016/j.endinu.2019.05.007
  7. Nano J, Carinci F, Okunade O, Whittaker S, Walbaum M, Barnard- Kelly K, Barthelmes D, Benson T, Calderon-Margalit R, Dennaoui J, Fraser S, Haig R, Hernández-Jimenéz S, Levitt N, Mbanya JC, Naqvi S, Peters AL, Peyrot M, Prabhaharan M, Pumerantz A, Raposo J, Santana M, Schmitt A, Skovlund SE, García-Ulloa AC, Wee HL, Zaletel J, Massi-Benedetti M; on behalf of the Diabetes Working Group of the International Consortium for Health Outcomes Measurement (ICHOM). A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach. Diabet Med. 2020 Mar 2. doi: 10.1111/dme.14286. [Epub ahead of print]
  8. Graue-Hernandez E, Rivera-De-La-Parra D, Hernandez-Jimenez S, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D, Jimenez-Corona A. Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes. BMJ Open Ophthalmology 2020;5: e000304. doi:10.1136/ bmjophth-2019-000304
  9. García-Ulloa AC, Palacios-Vargas A, Hernández-Jiménez S, for the Group of Study CAIPaDi. Diabetes in the COVID-19 emergency: what to assess remotely. Rev Mex Endocrinol Metab Nutr 2020; 7: 102-7 doi: 10.24875/RME.20000033
  10. Bello-Chavolla O, Bahena-López JP, Vargas-Vázquez A, Antonio-Villa NE, Márquez-Salinas A, Fermín-Martínez CA, Rojas R, Mehta R, Cruz- Bautista I, Hernández-Jiménez S, García-Ulloa AC, Almeda-Valdés P, Aguilar-Salinas CA, for the Metabolic Syndrome Study Group and the Group of Study CAIPaDi. Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach. BMJ Open Diab Res Care 2020; 8: e001550. doi:10.1136/ bmjdrc-2020-001550
  11. García-Ulloa AC, Almeda-Valdes P, Aguilar-Salinas CA, Hernández-Jiménez S, Group of Study CAIPaDi. Development and Validation of a Software Linked to an Internet Portal That Facilitates the Medical Treatment and Empowerment of Patients with Type 2 Diabetes, Interaction with Medical Personnel, and the Generation of a Real-Time Registry. Journal of Diabetes Science and Technology 2020; Aug:1932296820949941. doi: 10.1177/1932296820949941
  12. Antonio-Villa NE, Palma-Moreno BG, Rodríguez-Dávila FM, Gómez-Pérez FJ, Aguilar-Salinas CA, Hernández-Jiménez S, García-Ulloa AC, Almeda-Valdes P. Use of an electronic integral monitoring system for patients with diabetes to identify factors associated with an adequate glycemic goal and to measure quality of care. Primary Care Diabetes 2021; 15:162-168. doi.org/10.1016/j.pcd.2020.07.009
  13. Urbina-Arronte L, Vergara JJ, Villegas-Narváez A, García-Ulloa AC, Hernández-Jiménez S, for the Group of Study CAIPaDi. Evaluation of Heart Rate Recovery in Patients with Diabetes Mellitus Type 2 and Elevated Urine Albumin/Creatinine Ratio After an Individualized Exercise Program. Curre Res Diabetes & Obes J 2020; 13(4): 555870. DOI: 10.19080/CRDOJ.2020.13.555870.
  14. Ruiz-Cervantes GM, García-Ulloa AC, Palacios-Vargas A, Lechuga-Fonseca C, Sierra-Esquivel A, Velasco-Pérez ML, Hernández-Jiménez S, For the Group of Study CAIPaDi. Prevalence of Misconceptions about Diabetes and their Association with Metabolic and Psychological Variables. Diabetes Obes Int J 2021; 6(1): DOI: 10.23880/doij-16000238
  15. Almeda-Valdés P, Antonio-Villa NE, Rodríguez-Dávila FM, Palma-Moreno G, Gómez-Pérez FJ, Aguilar-Salinas CA, García-Ulloa AC, Hernández-Jiménez S. Comparison of two electronic systems for obtaining diabetes care indicators in clinical practice. Clinical Diabetes 2021; 39: 167-172 cd200069. doi.org/10.2337/cd20-0069
  16. Hernández-Jiménez S, García-Ulloa AC, Aguilar-Salinas CA, González-Flores E, Zúñiga-González S, Pérez-Sánchez P, Romero-Zazueta A, Vidrio-Velázquez M, Gómez-Pérez FJ, Kershenobich-Stalnikowitz D. Recomendaciones para el abordaje integral del paciente con diabetes tipo 2. Rev Mex Endocrinol Metab Nutr 2021; 8: 43-51 doi: 10.24875/RME.20001962
  17. García-Ulloa AC, Lechuga-Fonseca C, Del Razo-Olvera FM, Aguilar-Salinas CA, Galaviz KI, Venkat-Narayan KM, Hernández-Jiménez S, on behalf of Group of Study CAIPaDi. Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus. BMJ Open Diabetes Research & Care. 2021; 9: e001891. doi:10.1136/ bmjdrc-2020-001891
  18. Hernández-Jiménez S, García-Ulloa AC, Anaya P, Gasca-Pineda R, Sánchez-Trujillo LA, Peña-Baca H, González-Pier E, Graue-Hernández EO, Aguilar-Salinas CA, Gómez-Pérez FJ, Kershenobich-Stalnikowitz D, for the Group of Study CAIPaDi. Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City. BMJ Open Diab Res Care 2021; 9: e002097. doi:10.1136/ bmjdrc-2020-00209
  19. García-Ulloa AC, Ramírez-García JA, Díaz-Pineda M, Ovalle-Escalera CN, Arizmendi-Rodríguez R, Velasco-Pérez ML, Hernández-Jiménez S, for the Group of Study CAIPaDi. Results of Two Strategies for Peer-Support in Patients with Recently Diagnosed Type 2 Diabetes. Archives of Metabolic Syndrome 2021; 1(1): 1-7. DOI: AMSJ-2021-03
  20. Rodríguez-Reyes G, García-Ulloa AC, Hernández-Jiménez S, Alessi-Moreno A, Núñez-Carrera L, Rojas-Torres F, Infanzón-Talango H, Clark P, Miranda-Duarte A, Gómez-Díaz RA. Effect of whole-body vibration training on transcutaneous oxygen levels of the foot in patients with type 2 diabetes: a randomized controlled trial. J Biomechanics 2021; doi.org/10.1016/j.jbiomech.2021.11087
  21. Hernández-Jiménez S, García-Ulloa AC, Alcántara-Garcés MT, Urbina-Arronte LE, Lara-Sánchez C, Velázquez-Jurado H; for the Group of Study CAIPaDi. Feasibility and acceptance of a virtual multidisciplinary care programme for patients with type 2 diabetes during the COVID-19 pandemic. Ther Adv Endocrinol Metab 2021, Vol. 12: 1–10. HYPERLIdoi.org/10.1177/20420188211059882
  22. Alcántara-Garcés MT, Rodríguez-Ramírez AM, García-Ulloa AC, Hernández-Jiménez S. Comorbidity Between Recent Diagnosis of Type 2 Diabetes and Non-Psychotic Psychiatric Disorders: Metabolic Characteristics and Clinical Correlates. Neuropsychiatr Dis Treat. 2022;18:1151-1163 https://doi.org/10.2147/NDT.S364556
  23. Sevilla-Gonzalez M, Landa-Anell MV, Hernandez-Jimenez S, Melgarejo-Hernandez MA. Implementation of an Intervention Based on Nutritional Care Process to Improve Glycemic Parameters in a Type 2 Diabetes Comprehensive Care Program. The CAIPaDi Program. Curr Dev NUT 2022; Supp 1: 863. https://doi.org/10.1093/cdn/nzac065.047
  24. García Ulloa AC, Tron-Gómez MS, Díaz-Pineda M, Hernández-Juárez D, Landa-Anell MV, Melgarejo-Hernández MA, Hernández-Jiménez S. Maintenance of Self-Care Activities During COVID-19 Lockdown in Patients with Type 2 Diabetes That Received a Comprehensive Care Program Training. Diabetes Metab Syndr Obes. 2022; 15:2857-2865. https://doi.org/10.2147/DMSO.S379547
  25. García Ulloa AC, Díaz-Pineda M, Ramírez-García A, Antonio-Villa NE, Almeda-Valdés P, Kaufer-Horwitz M, Torres-Mejía G, Aguilar-Salinas CA, Hernández-Jiménez S, for the Group of Study CAIPaDi. The beneficial effect of a comprehensive diabetes care model on high-risk relatives accompanying patients with type 2 diabetes. Prim Care Diab 2022; 16:791-796 https://doi.org/10.1016/j.pcd.2022.09.008
  26. García-Ulloa AC, Almeda-Valdes P, Cuatecontzi-Xochitiotzi TE, Ramírez-García JA, Díaz-Pineda M, Garnica-Carrillo, González-Duarte A, Venkat-Narayan KM, Aguilar-Salinas CA, Hernández-Jiménez S, for the CAIPaDi Study Group. Detection of sudomotor alterations evaluated by Sudoscan in patients with recently diagnosed type 2 diabetes. BMJ Open Diab Res Care 2022;10:e003005. doi: 10.1136/bmjdrc-2022-003005
  27. Hernández-Jiménez S, García-Ulloa AC, González-Flores E, Hernández-Juárez D, Alcántara-Garcés MT, Rodríguez-Ramírez A, García-Padilla CE, Rull-Gabayet M, Landa-Anell MV, Melgarejo-Hernández M, Aguilar-Salinas CA. Tratamiento farmacológico multidisciplinario para la atención integral del paciente con diabetes tipo 2. Rev ALAD. 2022; 12:94-105. DOI: 10.24875/ALAD.22000018
  28. Rodríguez-Ramírez AM, Alcántara-Garcés MT, Hernández-Jiménez S, García-Ulloa AC, Arcila-Martínez D, Velázquez-Jurado H, Arizmendi-Rodríguez RE. Long-Term Effects of Anxiety on the Metabolic Control of Recently Diagnosed Type 2 Diabetes Patients: Results from the CAIPaDi Cohort Study. Neuropsychiatr Dis Treat. 2023; 19:197-207. https://doi.org/10.2147/NDT.S392672
  29. Velázquez-Jurado H, Flores-Torres A, Pérez-Peralta L, Salinas-Rivera E, Valle-Nava MD, Arcila-Martinez D, Hernández-Jiménez S, for the CAIPaDi Study Group. Cognitive behavioral treatment to improve psychological adjustment in people recently diagnosed with type 2 diabetes. Health Psychology and Behavioral Medicine 2023; 11: 2179058, DOI: 10.1080/21642850.2023.2179058
  30. Pérez-Peralta L, Rivera-De la Parra D, Graue-Hernández E, Hernández-Jiménez S, Almeda-Valdés P, Velázquez-Jurado H, Jiménez-Corona A. Discapacidad visual asociada a retinopatía diabética y edema macular: un estudio de base hospitalaria. Gac Med Mex 2023; 159: 207-14
  31. Hernández-Jiménez S, García-Ulloa AC, Infanzón-Talango H, Rojas-Torres F, Janka-Zires M, Aguilar-Salinas CA, Abbas ZG. The step-by-step program to lower the number of diabetic foot amputations in Mexico. Rev Mex Endocrinol Metab Nutr. 2023; 10:101-108. DOI: 10.24875/RME.22000066
  32. Villegas-Narváez LA, García-Ulloa C, Briseño-González O, Urbina-Arronte LE, Hernández-Jiménez S. Abordaje de las barreras para mejorar la adherencia a un programa de ejercicios en pacientes con diabetes tipo 2. Rev ALAD 2023; 13: 41-49. DOI: 10.24875/ALAD.23000008
  33. García-Ulloa AC, Pérez-Peralta L, Jaime-Casas S, Jiménez-Corona A, Rivera-De La Parra D, Graue-Hernández EO, Hernández-Jiménez S. Risk Factors Associated with Diabetic Retinopathy with and without Macular Edema in Recently Diagnosed Patients with Type 2 Diabetes. Diabetes Metab Syndr Obes 2024; 17: 231-238. https://doi.org/10.2147/DMSO.S447658
  34. García-Ulloa AC, Miranda-Gil V, Díaz-Pineda M, Garnica-Carrillo MF, Serrano-Pérez NH, Tron-Gomez MS, Colorado Báez GP, Cruz Madrigal CA, Hernández-Jiménez S. Comparison of Metabolic, Lifestyle and Mental Health Parameters in People with Diabetes and Relatives with and without Family Support. Diabetes Metab Syndr Obes 2024; 17:239-245 https://doi.org/10.2147/DMSO.S445890
  35. Alcántara-Garcés MT, Rodríguez-Ramírez AM, García-Ulloa AC, García-Alanis M, Martínez-Reyes GN, Del Moral Vidal LP, Arizmendi-Rodríguez Rodrigo, Hernández-Jiménez S, Almeda-Valdés P. Coping and risk perception during the COVID-19 pandemic in type 2 diabetes: ¿Does it influence Metabolic control? PLOS Glob Public Health 2024; 4(2): e0002793. https://doi.org/10.1371/journal.pgph.0002793
  36. García-Ulloa AC, Lugo-Bautista KS, Martínez-Sánchez V, Pérez-Peralta L, Hernández-Jiménez S. Metabolic comorbidities in relatives of patients with T2DM: Implications for Prevention and Care. IDF23-0559. Diabetes Research and Clinical Practice 2024; 209S1: 111539 https://doi.org/10.1016/j.diabres.2024.111539
  37. Rivera-De-la-Parra D, Hernández-Jiménez S, Almeda-Valdés P, Aguilar-Salinas CA, Graue-Hernández EO, Pérez-Peralta L, Jiménez-Corona A. Association between uric acid and referable diabetic retinopathy in patients with type 2 diabetes. Sci Rep 2024; 14: 12968. https://doi.org/10.1038/s41598-024-63340-0
  38. García-Ulloa AC, Cárdenas-Fragoso, JL, Hernández-Juárez D, Serrano-Pérez NH, Blancarte-Jaaber P, Mejía-Domínguez NR, Zentella-Dehesa A, Hernández-Jiménez S, for the Group of Study CAIPaDi. A case study on the implementation of quality and comprehensive indicators set in routine diabetes care. Arch Public Health 2024; 82: 121. https://doi.org/10.1186/s13690-024-01348-8
  39. Rojas-Torres F, Infanzón-Talango H, García-Ulloa AC, Hernández-Jiménez S, Rodríguez-Reyes G. Exploring plantar pressure distribution in patients with newly diagnosed diabetes: Implications for foot ulcer prevention in an overweight Mexican population, Endocrinología, Diabetes y Nutrición, 2024; https://doi.org/10.1016/j.endinu.2024.05.008
  40. Landa-Anell MV, Del Razo-Olvera FM, Bodnar I, Cordova-Isidro B, Lagunas-Valdepeña D, Arias-Marroquín AT, García-Ulloa AC, Melgarejo-Hernández MA, Hernández-Jiménez S. Nutritional diagnoses in people with type 2 diabetes: association with metabolic, anthropometric, and dietary parameters. Front. Nutr 2024: 11:1473429. https://doi.org/10.3389/fnut.2024.1473429
  41. Velázquez-Jurado H, Pérez-Peralta L, Valle-Nava D, Reynoso-Noverón N, Hernández-Jiménez S, Arcila-Martínez D, Arizmendi-Rodríguez R, Garnica-Carrillo F. Atención virtual en pacientes con diabetes tipo 2 durante la covid-19 [Virtual care in patients with type 2 diabetes during covid-19]. Rev Med Inst Mex Seguro Soc 2024; 4;62(2):1-8. doi: 10.5281/zenodo.10711427. PMID: 39508753
  42. Rivera-De La Parra D, Hernández-Jiménez S, Jiménez-Corona A, Pérez-Peralta L, Graue-Hernández EO, Aguilar-Salinas CA, et al. Factores de riesgo asociados a la referencia oftálmica urgente de pacientes diabéticos. Gac Med Mex. 2024;160(6):610-617. http://dx.doi.org/10.24875/GMM.M24000910
  43. García-Ulloa AC, Pérez-Peralta L, Lugo-Bautista K, Martínez-Sánchez VA, Mehta R, Hernández-Jiménez S. Metabolic Comorbidities Among Relatives of Type 2 Diabetes Patients Stratified by Weight: Implications for Prevention and Care. Diabetes Metab Syndr Obes. 2025;18:1539-1549 https://doi.org/10.2147/DMSO.S483171
  44. García-Ulloa AC, Pérez-Peralta L, Urbina-Arronte LE, Cárdenas-Fragoso JL, Landa-Anell MV, Melgarejo-Hernández MA, Gil VM, Ponce-de-León S, Hernández-Jiménez S; Group of Study CAIPaDi. Unveiling Longitudinal Weight Dynamics in Type 2 Diabetes: Insights From a Comprehensive Care Program. Arch Med Res. 2025 Aug 19;57(1):103271. doi: 10.1016/j.arcmed.2025.103271. Online ahead of print.PMID: 40834726
  45. Urbina Arronte LE, Alcántara Garcés MT, Ochoa Ramírez A, Velázquez Jurado HR, García Ulloa AC, Hernández Jiménez S. Metabolic, self-care and mental health characteristics of patients with type 2 diabetes in a hybrid (face-to-face and virtual) comprehensive care program. Therapeutic Advances in Endocrinology and Metabolism. 2025;16. doi:10.1177/20420188251367234












ACTUALIZACIÓN
Centro de Atención Integral del Paciente con Diabetes
2025